Income-related inequity in initiation of evidence-based therapies among patients with acute myocardial infarction
- PMID: 21751053
- PMCID: PMC3208463
- DOI: 10.1007/s11606-011-1799-1
Income-related inequity in initiation of evidence-based therapies among patients with acute myocardial infarction
Abstract
Background: Previous research has shown a socioeconomic status (SES) gradient in the receipt of cardiac services following acute myocardial infarction (AMI), but much less is known about SES and the use of secondary preventive medicines following AMI.
Objectives: To examine the role of income in initiation of treatment with ACE-inhibitors, beta-blockers and statins in the 120 days following discharge from hospital for first AMI.
Design: A cross-sectional study with a population-based cohort.
Participants: First-time AMI patients between age 40 and 100 discharged alive from the hospital and surviving at least 120 days following discharge between January 1, 1999 and September 3, 2006.
Main measures: Binary variables indicating whether the patient had filled at least one prescription for each of the medicines of interest.
Key results: Our results reveal a significant and positive income gradient with initiation of the guideline-recommended medicines among male AMI patients. Men in the third income quintile and above were significantly more likely to initiate treatment with any of the medicines than those in the first quintile, with those in the fifth income quintile having 37%, 50% and 71% higher odds of initiating ACE-inhibitors, beta-blockers and statins, respectively, than men in the lowest income quintile [OR = 1.37 95% CI (1.24, 1.51); OR = 1.50 95% CI (1.35, 1.68); and OR = 1.71 95% CI (1.53, 190)]. The gradient was not present among women, although women in the fifth income quintile were more likely to initiate beta-blockers and statins than women in the lowest income quintile [OR = 1.25 95% CI (1.06, 1.47) and OR = 1.32 95% CI (1.12, 1.54)].
Conclusions: There were inequities in treatment following AMI in the form of a clear and often significant gradient between income and initiation of evidence-based pharmacologic therapies among male patients. This gradient persisted despite significant changes in coverage levels for the costs of these medicines.
Conflict of interest statement
None disclosed
Similar articles
-
Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.J Am Coll Cardiol. 2017 Sep 26;70(13):1543-1554. doi: 10.1016/j.jacc.2017.07.783. J Am Coll Cardiol. 2017. PMID: 28935030 Free PMC article.
-
Use of statins and beta-blockers after acute myocardial infarction according to income and education.J Epidemiol Community Health. 2007 Dec;61(12):1091-7. doi: 10.1136/jech.2006.055525. J Epidemiol Community Health. 2007. PMID: 18000133 Free PMC article.
-
Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction.Intern Med. 2020 Jun 15;59(12):1489-1495. doi: 10.2169/internalmedicine.4016-19. Epub 2020 Mar 19. Intern Med. 2020. PMID: 32188806 Free PMC article.
-
Use of evidence-based pharmacotherapy after myocardial infarction in Estonia.BMC Public Health. 2010 Jun 23;10:358. doi: 10.1186/1471-2458-10-358. BMC Public Health. 2010. PMID: 20569449 Free PMC article.
-
[Management of acute myocardial infarction in the experience of a community hospital. A prospective study].Minerva Cardioangiol. 1997 Jul-Aug;45(7-8):335-47. Minerva Cardioangiol. 1997. PMID: 9463169 Review. Italian.
Cited by
-
Software-driven chronic disease management: Algorithm design and implementation in a community-based blood pressure control pilot.SAGE Open Med. 2024 Oct 31;12:20503121241284025. doi: 10.1177/20503121241284025. eCollection 2024. SAGE Open Med. 2024. PMID: 39494161 Free PMC article.
-
The mortality risk after myocardial infraction in migrants compared with natives: a systematic review and meta-analysis.Front Cardiovasc Med. 2023 May 24;10:1101386. doi: 10.3389/fcvm.2023.1101386. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37293275 Free PMC article. Review.
-
Assessing and Addressing Social Determinants of Cardiovascular Health: JACC State-of-the-Art Review.J Am Coll Cardiol. 2023 Apr 11;81(14):1368-1385. doi: 10.1016/j.jacc.2023.01.042. J Am Coll Cardiol. 2023. PMID: 37019584 Free PMC article. Review.
-
Association Between Social Vulnerability Index and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Study.J Am Heart Assoc. 2022 Aug 2;11(15):e024414. doi: 10.1161/JAHA.121.024414. Epub 2022 Jul 29. J Am Heart Assoc. 2022. PMID: 35904206 Free PMC article.
-
Association of Race and Ethnicity on the Management of Acute Non-ST-Segment Elevation Myocardial Infarction.J Am Heart Assoc. 2022 Jun 21;11(12):e025758. doi: 10.1161/JAHA.121.025758. Epub 2022 Jun 14. J Am Heart Assoc. 2022. PMID: 35699168 Free PMC article.
References
-
- Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association task force on practice guidelines: Developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation. 2008;117(2):296–329. doi: 10.1161/CIRCULATIONAHA.107.188209. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
